NCT03304431View on ClinicalTrials.gov

Evaluation of the Effect of 10% Lidocaine Spray Undergoing Coronary Artery Bypass Graft Operation

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

May 26, 2017

Primary Completion Date

August 20, 2017

Study Completion Date

September 20, 2017

Conditions
Cardiovascular DiseasesLidocaine Causing Adverse Effects in Therapeutic UseTracheal Intubation Morbidity
Interventions
DRUG

Orotracheal Lidocaine Oral Spray application

The induction of group L will be performed 5 minutes after administration of 10% topical lidocaine (Lidocaine pump spray 10% 50 ml) 160 mg (16 puffs) application

Trial Locations (1)

14280

Abant Izzet Baysal University Medical School,, Bolu

All Listed Sponsors
lead

Abant Izzet Baysal University

OTHER

NCT03304431 - Evaluation of the Effect of 10% Lidocaine Spray Undergoing Coronary Artery Bypass Graft Operation | Biotech Hunter | Biotech Hunter